Black kratom is not a naturally occurring variety of the kratom plant. It’s a marketing term for kratom that has been processed through fermentation, roasting, or both, giving the powder a noticeably darker color than standard red, green, or white strains. The base material is typically red vein kratom leaves that undergo additional heat treatment after harvest.
How Black Kratom Is Made
Standard kratom powders get their color classifications (red, green, white) primarily from how the leaves are dried after harvesting. Black kratom takes this a step further. Producers start with red vein kratom leaves and then ferment them, roast them, or apply both techniques in sequence. This extended processing darkens the powder well beyond the typical reddish-brown of a standard red strain.
The fermentation step involves exposing the leaves to moisture and heat over a period of time, encouraging chemical changes in the plant material. Roasting applies direct heat, similar to how coffee beans are darkened. Both processes alter the alkaloid profile of the leaves, which is why black kratom is often described as having stronger or different effects than the red strains it’s derived from.
What Processing Does to the Chemistry
Kratom’s primary active compound is mitragynine, which typically makes up about 1.2% of raw leaf material by weight. A second compound, 7-hydroxymitragynine, is far more potent but exists only in trace amounts in fresh leaves. Here’s where processing matters: 7-hydroxymitragynine is generated as an oxidative byproduct of mitragynine during drying and heat treatment. The more aggressively kratom is processed, the more mitragynine can convert into this stronger compound.
This conversion is a key reason black kratom is marketed as more potent. However, the degree of conversion varies enormously between products. A 2024 analysis published in the Journal of AOAC International tested several heavily processed kratom products and found 7-hydroxymitragynine concentrations ranging from 22 to 75 mg/g, while mitragynine levels dropped to just 2 to 6 mg/g. In unprocessed leaf, those numbers are essentially reversed. Not all black kratom products undergo this extreme level of processing, but the principle holds: darker, more processed kratom generally contains higher concentrations of 7-hydroxymitragynine relative to mitragynine.
Reported Effects Compared to Red Kratom
Users consistently describe black kratom as an amplified version of red strains. The most commonly reported effects lean heavily toward sedation and relaxation, with many users noting that it produces noticeably more drowsiness than the red varieties it originates from. People who use it often take it in the evening or at night for that reason.
Several popular black varieties exist, each based on their parent red strain:
- Black Bali is considered a more sedating version of Red Bali, with users reporting stronger pain-relieving properties.
- Black Maeng Da is described as producing the most sedation among black varieties.
- Black Thai is reported as more relaxing than its red counterpart, though somewhat milder than Black Maeng Da.
Because of the increased potency, users typically report needing smaller amounts of black kratom to achieve effects comparable to standard red strains. This is consistent with the chemistry: if processing concentrates the more potent alkaloid, less material would be needed for a similar effect.
How People Use It
Black kratom is sold in the same forms as other kratom products: loose powder, capsules, tablets, and sometimes liquid extracts or tinctures. Powder is the most common form and can be mixed into water, swallowed directly (a method called “toss and wash”), or blended into food and drinks. Capsules offer pre-measured amounts for people who dislike the taste, which is notably bitter.
Among regular kratom users in the U.S., most take between 1 and 3 grams per dose, with about a third using 4 to 6 grams. Because black kratom is reported to be more potent gram-for-gram than standard strains, experienced users often start with lower amounts than they would with a typical red powder.
Safety Concerns Worth Knowing
The increased processing that defines black kratom introduces specific risks beyond those associated with regular kratom use. The elevated 7-hydroxymitragynine levels are a particular concern. This compound acts more powerfully on opioid receptors in the brain, which raises the potential for dependence, withdrawal symptoms, and adverse reactions.
The FDA has issued warnings about specific black kratom products. One notable case involved OPMS Black Liquid Kratom, a concentrated extract linked to serious adverse effects including death. Reported problems with that product included withdrawal symptoms, addiction, digestive issues, restless leg syndrome, skin problems, increased anxiety, and difficulty concentrating. The FDA broadly warns that kratom carries risks of liver toxicity, seizures, and substance use disorder.
The JAOAC analysis also revealed a labeling problem. Several products tested contained 7-hydroxymitragynine at levels 5 to 28% higher than what their labels claimed, while mitragynine levels were substantially lower than expected for genuine kratom. Some products marketed as “kratom” appeared to be spiked with synthetic 7-hydroxymitragynine rather than containing it naturally from processed leaf material. This makes buying black kratom from unverified sources particularly risky, since you may not know what’s actually in the product.
Black Kratom vs. Black Label Kratom
One point of confusion: “black kratom” and “black label kratom” are sometimes used interchangeably, but they can mean different things depending on the vendor. Some companies use “black label” simply to indicate their strongest product line, which might be a concentrated extract rather than fermented leaf powder. Others use it specifically for the fermented or roasted product described above. If you see “black” on a kratom label, checking whether it refers to a processing method or just a branding choice matters, since extracts and fermented powders have very different potency profiles and risks.